immunologically privileged sites
Definition: sites where allografts are not readily rejected or tumors escape immune surveillance probably because these particular areas have poor lymphatic drainage, are not readily accessible to effector cells of the immune system, central nervous system or involve immune-tolerance mechanisms.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
© Copyright 2018 Wolters Kluwer. All Rights Reserved. Review date: Sep 19, 2016.